Clinical grade growth Rising demand for pharma-grade and growth factor capsules signals opportunities to cross-sell to dermatology clinics, med-spas, and high-end skincare retailers seeking scientifically validated delivery systems and premium serums.

Clinical tech leverage Droplette’s Microinfusion platform enables deeper delivery of large molecules, presenting upsell potential to professional skincare providers and B2B distributors seeking devices that offer measurable dermal impact and differentiation from traditional topicals.

Science backed credibility Recognition as TIME Best Inventions and Edison Award underscores credibility with dermatology professionals and invested consumers, creating openings to pursue partnerships, clinical studies, and co-branding with prestige SKUs.

Growth runway Current revenue range and recent fundraising indicate growth velocity; engage strategic investors and channel partners for expanded distribution, including spa networks, cosmetic retailers, and D2C collaborations.

Operational scale Small team size relative to peers suggests partnering with contract manufacturers, logistics providers, and clinical research firms to scale production, cold-chain distribution for Factor capsules, and international expansion.